SCHEMBL19633928

SCHEMBL19633928

Clc1ccc(C(c2ccccc2)c2ccc(Cl)[nH]2)[nH]1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.39
ATM Q13315 1/20 0.39
TSHR P16473 1/20 0.37
SLC6A2 P23975 3/20 0.37
SLC6A4 P31645 3/20 0.37
SLC6A3 Q01959 3/20 0.37
CFTR P13569 1/20 0.33
GOPC Q9HD26 1/20 0.33
TP53 P04637 1/20 0.33
MAPT P10636 1/20 0.33
MEN1 O00255 1/20 0.33
POLB P06746 1/20 0.33
DPP4 P27487 2/20 0.32
F2 P00734 1/20 0.32
IDO1 P14902 1/20 0.31
TDO2 P48775 1/20 0.31
CHRM2 P08172 1/20 0.31
CHRM4 P08173 1/20 0.31
CHRM5 P08912 1/20 0.31
CHRM1 P11229 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19633944 0.88 SLC6A2 (0.33) KMT2AATMSLC6A2SLC6A4SLC6A3
SCHEMBL19622556 0.79 ESR1 (0.38) KMT2ATSHRSLC6A2SLC6A3MAPT
SCHEMBL23996388 0.74 KMT2A (0.39) KMT2AATMTSHRSLC6A2SLC6A4
SCHEMBL16270678 0.71 SLC6A2 (0.39) KMT2AATMTSHRSLC6A2SLC6A4
SCHEMBL24671964 0.71 SLC6A2 (0.39) KMT2AATMTSHRSLC6A2SLC6A4
SCHEMBL12246830 0.69 KMT2A (0.36) KMT2AATMSLC6A2SLC6A4SLC6A3
SCHEMBL12629680 0.69 KMT2A (0.36) KMT2AATMSLC6A2SLC6A4SLC6A3
SCHEMBL11932651 0.69 TP53 (0.38) KMT2AATMSLC6A2SLC6A4SLC6A3
SCHEMBL27907795 0.66 SLC6A2 (0.67) KMT2AATMTSHRSLC6A2SLC6A4
SCHEMBL144 0.66 SLC6A2 (0.67) KMT2AATMTSHRSLC6A2SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3612538-B1 QUINONE-METHIDE PRECURSORS WITH BODIPY CHROMOPHORE, METHOD OF PREPARATION, BIOLOGICAL ACTIVITY AND APPLICATION IN FLUORESCENT LABELLING RUDJER BOSKOVIC INST (HR) 2021-01-13 EP disclosed
US-20200197423-A1 Quinone-methide precursors with bodipy chromophore, method of preparation, biological activity and application in fluorescent labelling RUDJER BOSKOVIC INSTITUTE (HR) 2020-06-25 US disclosed
WO-2017199056-A1 QUINONE-METHIDE PRECURSORS WITH BODIPY CHROMOPHORE, METHOD OF PREPARATION, BIOLOGICAL ACTIVITY AND APPLICATION IN FLUORESCENT LABELLING RUDJER BOSKOVIC INSTITUTE (HR) 2017-11-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200197423-A1 Quinone-methide precursors with bodipy chromophore, method of preparation, biological activity and application in fluorescent labelling NQO2, NQO1, CYBA KMT2A 1868/4885ATM 3726/4885TSHR 4324/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.